Company Name: ProNAi Therapeutics Inc.
ProNAi Therapeutics Inc. is a clinical-stage oncology company. The company uses its proprietary DNAi technology platform to develop therapeutics for cancer and hematological diseases. The company’s lead product candidate is designed to target cancers that overexpress the oncogene BCL2.
Ticker Symbol: DNAI (NASDAQ)
Company Website: http://pronai.com
Social Media:
Classification: Biotech
Areas of Focus: Cancer
Headquarters: Vancouver, BC Canada
Related Links:
List of Pharmaceutical Companies
List of Canadian Stocks on U.S. Exchanges
Foreign Stocks on U.S. Exchanges
Publicly Traded Companies by Sector and Industry